Intramolecular hydrogen-bonding in beta adrenergic blocking agents

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Physical Chemistry

Background:

• Beta-adrenergic blocking agents are crucial in managing cardiovascular conditions.
• Understanding their physicochemical properties, such as acid dissociation constants (pK(a)), is vital for drug design and efficacy.
• The alkanolamine side-chain is a common structural feature in this drug class.

Purpose of the Study:

• To determine the acid dissociation constants (pK(a)) for nine beta-adrenergic blocking agents.
• To elucidate the structural basis for the observed pK(a) values.
• To investigate the role of intramolecular hydrogen bonding in modulating drug properties.

Main Methods:

• Determination of acid dissociation constants (pK(a)) using potentiometric or spectrophotometric titration.
• Analysis of drug structures to identify potential intramolecular interactions.
• Computational modeling to support proposed hydrogen bonding interactions.

Main Results:

• The acid dissociation constants (pK(a)) for nine beta-adrenergic blocking agents were successfully determined.
• Unusually low pK(a) values were observed for these compounds.
• Evidence suggests the formation of an intramolecular hydrogen bond between the terminal amino group and the beta-hydroxyl group.

Conclusions:

• The low pK(a) values of these beta-adrenergic blocking agents are attributed to intramolecular hydrogen bond formation.
• This hydrogen bond stabilizes the protonated form of the drug, influencing its ionization state.
• The findings provide insights into the structure-property relationships of beta-adrenergic blocking agents, relevant for drug development.